Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).
- DOI
- 10.1002/jcph.70057
- Published
- 2025 Nov
- Container
- Journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jcph.70057,
title = {Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).},
author = {Balevic SJ and Gonzalez D and Smith PB and Powderly WG and Schmid A and Kang A and McCarthy MW and Shaw LK and Lindsell CJ and Bozzette S and Hoetelmans RMW and Hornik CP and Benjamin DK Jr and ACTIV‐1 IM Study Group Members},
year = {2025},
journal = {Journal of clinical pharmacology},
doi = {10.1002/jcph.70057},
url = {https://doi.org/10.1002/jcph.70057}
}RIS
TY - JOUR TI - Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM). AU - Balevic SJ AU - Gonzalez D AU - Smith PB AU - Powderly WG AU - Schmid A AU - Kang A AU - McCarthy MW AU - Shaw LK AU - Lindsell CJ AU - Bozzette S AU - Hoetelmans RMW AU - Hornik CP AU - Benjamin DK Jr AU - ACTIV‐1 IM Study Group Members PY - 2025 JO - Journal of clinical pharmacology DO - 10.1002/jcph.70057 UR - https://doi.org/10.1002/jcph.70057 ER -
APA
SJ, B., D, G., PB, S., WG, P., A, S., A, K., MW, M., LK, S., CJ, L., S, B., RMW, H., CP, H., Jr, B. D., & Members, A. I. S. G. (2025). Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).. Journal of clinical pharmacology. https://doi.org/10.1002/jcph.70057
Source records
- pubmed · retrieved 2026-09-25T00:07:21.717Z